Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthesia Depth Monitoring and Dexmedetomidine in VP Shunt Surgery
NCT06005363Recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Jul 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD) (3 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Postoperative cognitive function and NMR and LC-MS CSF and plasma metabolomics. Started Jul 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT06005363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06005363.